BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
HIV infection
,
Neuron
,
Avian flu virus
,
Doxorubicin
,
rs6983267
,
MYC
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CD30
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Myeloid cells of peripheral blood
Macrophage of peripheral blood
Monocyte of peripheral blood
Neutrophil of bone marrow
Granulocyte-macrophage progenitor cell of bone marrow
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Infection due to Citrobacter
Herpesvirus infection
T-cell lymphoma
Toxoplasmosis
Cryptococcosis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Perhexiline
monastrol
CEP 14083
4-1BB Ligand
Aclarubicin
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
EGLN3
MXD3
PAAF1
CRX
PWWP2A
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Spatially Resolved Transcriptomes of CD30+-Transformed Mycosis Fungoides and Cutaneous Anaplastic La…
Expression and Clinical Significance of CD30 and CD56 in Lymphoblastic Lymphoma: A Retrospective Ana…
CD30 plays a role in T-dependent immune response and TÂ cell proliferation.
The Polyvalent Role of CD30 for Cancer Diagnosis and Treatment.
CD30+ lymphoproliferative disorder masquerading as an atypical melanocytic proliferation.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
CD30biAb-AATC for CD30+ Malignancies
CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma
Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL
Camrelizumab Combined With CD30 CAR-T in the Treatment of Relapsed/Refractory CD30+ Lymphoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ